About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Medical Oncology
›
top-articles
Medical Oncology
2.8
(top 20%)
impact factor
4.2K
(top 5%)
papers
83.8K
(top 5%)
citations
90
(top 5%)
h
-index
2.9
(top 20%)
impact factor
4.3K
all documents
88.0K
doc citations
127
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation
Medical Oncology
2012
529
2
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
Medical Oncology
2011
526
3
Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies
Medical Oncology
2011
496
4
Treatment Resistance of Solid Tumors
Medical Oncology
2001
471
5
Long-term survival with metastatic cancer to the brain
Medical Oncology
2000
260
6
Metformin and cancer: new applications for an old drug
Medical Oncology
2012
254
7
Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
Medical Oncology
2009
239
8
The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients
Medical Oncology
2014
239
9
High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
Medical Oncology
2012
225
10
Upregulated INHBA expression is associated with poor survival in gastric cancer
Medical Oncology
2012
212
11
Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells
Medical Oncology
2011
210
12
Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients
Medical Oncology
2013
206
13
Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells
Medical Oncology
2010
201
14
Current status of enhanced recovery after surgery (ERAS) protocol in gastrointestinal surgery
Medical Oncology
2018
197
15
Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma
Medical Oncology
2014
196
16
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
Medical Oncology
2012
187
17
The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
Medical Oncology
2010
186
18
Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) Results of Protocol E1293
Medical Oncology
1996
183
19
Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer
Medical Oncology
2013
169
20
Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer
Medical Oncology
2014
167
21
Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer
Medical Oncology
2014
164
22
MicroRNA-21 is involved in osteosarcoma cell invasion and migration
Medical Oncology
2011
161
23
Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer
Medical Oncology
2013
161
24
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
Medical Oncology
2012
159
25
Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy
Medical Oncology
2017
156
26
The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications
Medical Oncology
2020
145
27
Steps in metastasis: an updated review
Medical Oncology
2021
141
28
Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray
Medical Oncology
2012
140
29
MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis
Medical Oncology
2012
138
30
Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients
Medical Oncology
2012
137
31
Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer
Medical Oncology
2014
135
32
Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway
Medical Oncology
2015
135
33
CTC clusters in cancer progression and metastasis
Medical Oncology
2017
134
34
Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life
Medical Oncology
2010
132
35
Salivary biomarkers in cancer detection
Medical Oncology
2017
131
36
Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy
Medical Oncology
2016
129
37
The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data
Medical Oncology
2017
129
38
Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
Medical Oncology
2012
127
39
O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation
Medical Oncology
2012
126
40
Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer
Medical Oncology
2012
125
41
A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer
Medical Oncology
2017
125
42
The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma
Medical Oncology
2018
124
43
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
Medical Oncology
2013
121
44
The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients
Medical Oncology
2011
120
45
miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells
Medical Oncology
2012
120
46
Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients
Medical Oncology
2013
120
47
Percutaneous image-guided cryoablation: current applications and results in the oncologic field
Medical Oncology
2016
120
48
The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer
Medical Oncology
2012
119
49
c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer
Medical Oncology
2014
119
50
Spontaneous remission of “methotrexate-associated lymphoproliferative disorders” after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature
Medical Oncology
2009
118
site/software ©
exaly
; All materials licenced under
CC by-SA
.